Do p38 MAPK inhibitors have a future for the treatment of cardiovascular disease?

Andrew R. Kompa

Research output: Contribution to journalArticleOtherpeer-review

Original languageEnglish
Pages (from-to)E1068-E1071
JournalJournal of Thoracic Disease
Volume8
Issue number9
DOIs
Publication statusPublished - Sep 2016

Cite this

@article{5e3cf9d255fb4bc5a153f70375af608f,
title = "Do p38 MAPK inhibitors have a future for the treatment of cardiovascular disease?",
author = "Kompa, {Andrew R.}",
year = "2016",
month = "9",
doi = "10.21037/jtd.2016.07.94",
language = "English",
volume = "8",
pages = "E1068--E1071",
journal = "Journal of Thoracic Disease",
issn = "2072-1439",
number = "9",

}

Do p38 MAPK inhibitors have a future for the treatment of cardiovascular disease? / Kompa, Andrew R.

In: Journal of Thoracic Disease, Vol. 8, No. 9, 09.2016, p. E1068-E1071.

Research output: Contribution to journalArticleOtherpeer-review

TY - JOUR

T1 - Do p38 MAPK inhibitors have a future for the treatment of cardiovascular disease?

AU - Kompa, Andrew R.

PY - 2016/9

Y1 - 2016/9

U2 - 10.21037/jtd.2016.07.94

DO - 10.21037/jtd.2016.07.94

M3 - Article

VL - 8

SP - E1068-E1071

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

SN - 2072-1439

IS - 9

ER -